BACKGROUND: Many studies performed on nontraditional risk factors have proposed a metabolic triad including increased serum level of apolipoprotein B, hyperinsulinemia and high small, dense LDL-C as a risk factor of cardiovascular diseases. Hypertriglycemic waist (increased waist circumference as well as high fasting triglyceride level) can be used as a simple criterion to predict the metabolic triad. The aim of this study was to investigate the prevalence of hypertriglycemic waist and the frequency of cardiovascular risk factors in the affected population. MATERIALS AND METHODS: The study was performed on 4169, 18-70 y-old male subjects of the population of Tehran Lipid and Glucose Study (TLGS). The subjects fell into four groups with respect to serum level of fasting triglycerides (Tg) and waist circumference (WC). Subjects of group 1 had serum Tg > or =1.8 mmol/l as well as WC > or =95 cm, while those of group 2 had Tg > or =1.8 mmol/l and WC <95 cm. The triglycerides level was less than 1.8 mmol/l in groups 3 and 4, whereas WC was > or =95 cm and lower than 95 cm, respectively. Cardiovascular risk factors, anthropometric and laboratory variables were compared between the groups. RESULTS: In total, 784 subjects had high serum levels of Tg as well as increased WC. The mean age of subjects was significantly higher in groups 1 and 3 compared to others (37+/-15, 48+/-14, 41+13 and 46+/-13 y of age in groups 4, 3, 2 and 1, respectively, P<0.001). The prevalence of cardiovascular risk factors was significantly higher in group 1 as compared with others. Systolic and diastolic blood pressure, body mass index and WC were significantly higher in group 1 than in the others. Serum total cholesterol, Tg and LDL-C were significantly higher in group 1 compared to others, whereas HDL-C was significantly lower in this group. The prevalence of subjects who had at least four risk factors was 75 and 8% in groups 1 and 4, respectively. CONCLUSION: Hypertriglycemic waist can be used as a simple criterion to predict cardiovascular risk factors.
BACKGROUND: Many studies performed on nontraditional risk factors have proposed a metabolic triad including increased serum level of apolipoprotein B, hyperinsulinemia and high small, dense LDL-C as a risk factor of cardiovascular diseases. Hypertriglycemic waist (increased waist circumference as well as high fasting triglyceride level) can be used as a simple criterion to predict the metabolic triad. The aim of this study was to investigate the prevalence of hypertriglycemic waist and the frequency of cardiovascular risk factors in the affected population. MATERIALS AND METHODS: The study was performed on 4169, 18-70 y-old male subjects of the population of Tehran Lipid and Glucose Study (TLGS). The subjects fell into four groups with respect to serum level of fasting triglycerides (Tg) and waist circumference (WC). Subjects of group 1 had serum Tg > or =1.8 mmol/l as well as WC > or =95 cm, while those of group 2 had Tg > or =1.8 mmol/l and WC <95 cm. The triglycerides level was less than 1.8 mmol/l in groups 3 and 4, whereas WC was > or =95 cm and lower than 95 cm, respectively. Cardiovascular risk factors, anthropometric and laboratory variables were compared between the groups. RESULTS: In total, 784 subjects had high serum levels of Tg as well as increased WC. The mean age of subjects was significantly higher in groups 1 and 3 compared to others (37+/-15, 48+/-14, 41+13 and 46+/-13 y of age in groups 4, 3, 2 and 1, respectively, P<0.001). The prevalence of cardiovascular risk factors was significantly higher in group 1 as compared with others. Systolic and diastolic blood pressure, body mass index and WC were significantly higher in group 1 than in the others. Serum total cholesterol, Tg and LDL-C were significantly higher in group 1 compared to others, whereas HDL-C was significantly lower in this group. The prevalence of subjects who had at least four risk factors was 75 and 8% in groups 1 and 4, respectively. CONCLUSION: Hypertriglycemic waist can be used as a simple criterion to predict cardiovascular risk factors.
Authors: Isabelle Lemieux; Paul Poirier; Jean Bergeron; Natalie Alméras; Benoît Lamarche; Bernard Cantin; Gilles R Dagenais; Jean-Pierre Després Journal: Can J Cardiol Date: 2007-10 Impact factor: 5.223
Authors: Ki Joong Han; Shin Yeoung Lee; Nam Hee Kim; Hyun Beom Chae; Tae Hoon Lee; Choel Min Jang; Kyung Mo Yoo; Hae Jung Park; Min Kyung Lee; Won Seon Jeon; Se Eun Park; Cheol Young Park; Won Young Lee; Ki Won Oh; Sung Woo Park; Eun Jung Rhee Journal: Endocrinol Metab (Seoul) Date: 2014-07-02
Authors: Peyman Namdarimoghaddam; Adeleke Fowokan; Karin H Humphries; G B John Mancini; Scott Lear Journal: BMC Cardiovasc Disord Date: 2021-02-02 Impact factor: 2.298
Authors: Danijela Gasevic; Axel C Carlsson; Iris A Lesser; Gb John Mancini; Scott A Lear Journal: Lipids Health Dis Date: 2014-02-23 Impact factor: 3.876
Authors: Manju Mamtani; Hemant Kulkarni; Thomas D Dyer; Harald H H Göring; Jennifer L Neary; Shelley A Cole; Jack W Kent; Satish Kumar; David C Glahn; Michael C Mahaney; Anthony G Comuzzie; Laura Almasy; Joanne E Curran; Ravindranath Duggirala; John Blangero; Melanie A Carless Journal: Clin Epigenetics Date: 2016-01-20 Impact factor: 6.551
Authors: Priscila Ribas de Farias Costa; Ana Marlúcia Oliveira Assis; Carla de Magalhães Cunha; Emile Miranda Pereira; Gabriela Dos Santos de Jesus; Lais Eloy Machado da Silva; Wilanne Pinheiro de Oliveira Alves Journal: Arq Bras Cardiol Date: 2017-05-25 Impact factor: 2.000